Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma leukemia effects and safety von Hoyos, V, Savoldo, B, Quintarelli, C, Mahendravada, A, Zhang, M, Vera, J, Heslop, H E, Rooney, C M, Brenner, M K, Dotti, G

Volltext

Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis von APPEL, S. H, ENGELHARDT, J. I, BRENNER, M. K, POPAT, U, HENKEL, J. S, SIKLOS, L, BEERS, D. R, YEN, A. A, SIMPSON, E. P, LUO, Y, CARRUM, G, HESLOP, H. E

Volltext

The immunogenicity of virus-derived 2A sequences in immunocompetent individuals von Arber, C, Abhyankar, H, Heslop, H E, Brenner, M K, Liu, H, Dotti, G, Savoldo, B

Volltext

Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath) von MYERS, G. D, KRANCE, R. A, WEISS, H, KUEHNLE, I, DEMMLER, G, HESLOP, H. E, BOLLARD, C. M

Volltext

Engineering haploidentical transplants von Naik, S, Heslop, H E

Volltext

Combined autologous CD30.CAR‐T cells and nivolumab in patients with relapsed or refractory classical Hodgkin Lymphoma after failure of frontline therapy (ACTION study) von Ahmed, S., Mei, M., Kurtz, D. M., Beitinjaneh, A., Grover, N. S., Ramos, C. A., Chabon, J. J., Schultz, A., Ding, C., Myo, A., Alizadeh, A. A., Horak, I. D., Heslop, H. E.

Volltext

OFF‐THE‐SHELF CD30.CAR‐MODIFIED EPSTEIN‐BARR VIRUS‐SPECIFIC T CELLS (CD30.CAR EBVSTS) PROVIDE A SAFE AND EFFECTIVE THERAPY FOR PATIENTS WITH HODGKIN LYMPHOMA (HL) von Ramos, C. A., Quach, D. H., Lulla, P. D., Rouce, R. H., Sharma, S., Ganesh, H. R., Nouraee, N., Briones, Y. D., Becerra‐Dominguez, L., Thakkar, S. G., Mehta, B., Perconti, S., Hsieh, E. M., Zhang, H., Grilley, B. J., Lapteva, N., Brenner, M. K., Heslop, H. E., Rooney, C. M.

Volltext

Adoptive cellular immunotherapy for viral diseases von Fujita, Y, Rooney, C M, Heslop, H E

Volltext

Adenovirus infection after pediatric bone marrow transplantation von HALE, G. A, HESLOP, H. E, KRANCE, R. A, BRENNER, M. A, JAYAWARDENE, D, SRIVASTAVA, D. K, PATRICK, C. C

Volltext

Transmission of integrated human herpesvirus-6 in allogeneic hematopoietic stem cell transplantation von KAMBIE, R. T, CLARK, D. A, LEONG, H. N, HESLOP, H. E, BRENNER, M. K, CARRUM, G

Volltext

Efficient infection of primitive hematopoietic stem cells by modified adenovirus von YOTNDA, P, ONISHI, H, HESLOP, H. E, SHAYAKHMETOV, D, LIEBER, A, BRENNER, M, DAVIS, A

Volltext

Efficacy of deferred dosing of granulocyte colony-stimulating factor in autologous hematopoietic transplantation for multiple myeloma von Cox, J E, Campos, S, Wu, J, May, R, Liu, H, Ramos, C A, Carrum, G, Heslop, H E, Brenner, M K, Kamble, R T

Volltext

Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation von MYERS, G. D, BOLLARD, C. M, WU, M-F, WEISS, H, ROONEY, C. M, HESLOP, H. E, LEEN, A. M

Volltext

CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation von Kuehnle, Ingrid, Huls, M. Helen, Liu, Zhensheng, Semmelmann, Micah, Krance, Robert A., Brenner, Malcolm K., Rooney, Cliona M., Heslop, Helen E.

Volltext

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation von Rooney, C.M, Ng, C.Y.C, Loftin, S, Smith, C.A, Li, C, Krance, R.A, Brenner, M.K, Heslop, H.E, Rooney, C.M, Brenner, M.K, Brenner, M.K, Krance, R.A, Heslop, H.E

Volltext

Neuropathic dermatomes and cutaneous ulceration in patients with chronic GVHD von Kamble, R T, Scholoff, A, Obi, A G, Heslop, H E, Brenner, M K, Carrum, G

Volltext

Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients von ROONEY, C. M, SMITH, C. A, HESLOP, H. E, NG, C. Y. C, LOFTIN, S. K, SIXBEY, J. W, YANJUN GAN, SRIVASTAVA, D.-K, BOWMAN, L. C, KRANCE, R. A, BRENNER, M. K

Volltext

Use of highly characterized EBV-Specific T Cells outside of the immediate Post-Transplant setting von Rouce, R.H, Thakkar, A, Sharma, S, Shah, N, Reyna, A, Ramos, C.A, Lapteva, N, Zhang, H, Mehta, B, Perconti, S, McKenna, M, Gee, A.P, Lulla, P.D, Castello, J, Brenner, M, Heslop, H, Rooney, C

Volltext

Selective elimination of a chemoresistant side population of B-CLL cells by cytotoxic T lymphocytes in subjects receiving an autologous hCD40L IL-2 tumor vaccine von Foster, A E, Okur, F V, Biagi, E, Lu, A, Dotti, G, Yvon, E, Savoldo, B, Carrum, G, Goodell, M A, Heslop, H E, Brenner, M K

Volltext

Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy von Cruz, C. R. Y., Lam, S., Hanley, P. J., Bear, A. S., Langston, C., Cohen, A. J., Liu, H., Martinez, C. A., Krance, R. A., Heslop, H. E., Rooney, C. M., Hanson, I. C., Bollard, C. M.

Volltext